uterine corpus leiomyoma
uterine corpus leiomyoma
Explore linked clinical trials. Standard reference: MONDO:00078861 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, connective tissue disorder, connective tissue neoplasm, epithelial neoplasm, hereditary leiomyomatosis and renal cell cancer, kidney cancer, kidney disorder, leiomyoma cutis, myofibroma, neoplasm, renal cell carcinoma, urinary system disorder, uterine corpus leiomyoma | Not yet recruiting | Phase 1 | 2026-08-06 | NCT07716735 |